Logo Regione Autonoma della Sardegna
sardegnaricerche  ›  ...  ›  technology park  ›  tenants  ›  asi srl

ASI srl

Escherichia Coli bacteria on a Petri dish
Science and Technology Park of Sardinia
S.P. 55 Porto Conte-Capo Caccia
Km 8,400, 07041 Alghero (SS) - Italy
Phone +39 079 998447
Indirizzo emailgmotolese@yahoo.it

ASI is an Italian biotech company that rests on studies beginning back in the 1990s to test novel systems for automated somatic cell counting in dairy milk through fluorescence correlation spectroscopy.

The instrument developed and its detection method were later extended to all other types of fluorescence-marked cells and were successfully applied to count, in addition to somatic cells, bacteria, viruses and even macromolecules. The instrument and its technique were patented in the US in May 2009. The European patent application is currently pending.

Competences and technologies
The company has recently developed new rapid microbiological methods replacing traditional in vitro cultures, cutting down response time from several days to just a few minutes.

ASI's current activities focus on the following areas:
1. urine screening with immediate detection of negative samples, thus reducing the administration of antibiotics to patients not affected by bacterial urinary infections
2. monitoring of drinkable, bottled and natural mineral water, with real-time detection of pathogens enabling fast remedial actions
3. microbiological control of the hospital environment, especially operating theatres
4. screening for infectious diseases constituting a public health threat, e.g. renal tuberculosis
5. prevention of Legionellosis.

ASI is currently engaged in the development of several projects, which have obtained funding from the following institutions:
1. Sardegna Ricerche, for renal tuberculosis screening in facilities having a high concentration of population at risk, such as reception centres for immigrants incoming from areas where this infection is endemic
2. The Region of Lombardy, for fast urine screening, in order to control use of antibiotics and fight the spread of antibiotic-resistant bacterial strains.